Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study Evaluating Efficacy and Safety of CPI-613 in Combination With HD Cytarabine and Mitoxantrone vs HD Cytarabine and Mitoxantrone in Older Patients With R/R AML

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03504410
Recruitment Status : Recruiting
First Posted : April 20, 2018
Last Update Posted : June 12, 2019
Sponsor:
Information provided by (Responsible Party):
Rafael Pharmaceuticals Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : October 2022
  Estimated Study Completion Date : March 2023